Provided by Tiger Fintech (Singapore) Pte. Ltd.

SELLAS Life Sciences Group Inc.

1.09
+0.0000
Post-market: 1.090.00000.00%18:11 EDT
Volume:733.72K
Turnover:804.82K
Market Cap:99.02M
PE:-2.16
High:1.12
Open:1.09
Low:1.07
Close:1.09
Loading ...
Aug 13, 2020

Major Issues Report

8-K - Current report
Aug 04, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 29, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 14, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 13, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 13, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 17, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 1.01, 1.02, 3.02, and 9.01
Jan 07, 2020

Major Issues Report

Current report, items 1.01, 3.03, and 9.01
Nov 25, 2019

Major Issues Report

Current report, item 8.01
Nov 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]